MING FONG TECHNOLOGY CO., LTD.

MING FENG Technology\\\'s VIROCRUSH patented technology was initially invested in research and development to address the needs of medical customers for antibacterial and antiviral products to help reduce bacterial and viral infections that may be caused by product use in the environment. After several years of arduous research and development, The process research and development was officially completed at the end of 2019 and the mass production phase was launched. Shortly afterwards, the global COVID-19 outbreak occurred. Mingfeng hopes that VIROCRUSH technology can contribute to the global fight against the virus!

Ministry of Agriculture

Health-related agricultural biotechnology research and development achievements and industrialized products.

miRoncol Health

miRoncol Health will launch the first-of-its-kind microRNA based mutli-cancer risk stratification blood test in 2026. The AI powered blood test will benefit more healthy individuals to leverage existing advanced cancer assessment programs to detect cancers early beyond current cancer screening technologies. The proof of concept studies demonstrated superior performance particularly for early stage cancers with ~90% sensitivity at 99%+ specificity among ~80% common solid tumors other than breast cancer. It outperforms mainstream ctDNA based tests and is also more affordable due to requiring only a few microRNAs and using widely available PCR technology.

MOBISNET TECHNOLOGY CO., LTD.

Founded in 2003, it is a professional service robot company in Taiwan. It has a professional team of R&D, design and planning. With the ability to continuously absorb and integrate innovative technologies, it is committed to providing high-quality robot automation solutions and has successfully built a complete robot platform to provide high-quality software and hardware integration solutions in the fields of Industry 4.0, medical care, department store retail, catering, accommodation, education and scientific research. Bojun Technology has established Taiwan\\\'s leading brand of independent research and development of service robots, injecting new blood into the service robot industry, and successfully promoted its solutions to the world, demonstrating Taiwan\\\'s robot research and development capabilities.
Product name: AMR handling robot: load 50KG, load 100KG, load 300KG Service robots: Iris service robot, Vida service robot, Nuta delivery robot, Dali food delivery robot, Kevi security patrol robot, Era spray disinfection robot.

MODERNSOLID INDUSTRIAL CO., LTD

Bedside infotainment Arm、Ultra Slim Hospital Arm. Hosputal LCD/TV Monitor Arm、 Medical Computing /Equipment Cart、 Medical Cart
AI Healthcare System Equipment, AI Telemedicine Equipment, Instrument carts,
Smart Hospital Equipment,,

Mold-Masters Co., Ltd

Mold-Masters is a global leader in the plastics industry. We design, manufacture, distribute, sell and service highly engineered and customized plastic processing equipment and systems. Our hot runners, temperature controllers, auxiliary injection and co-injection systems are utilized by customers of all sizes in every industry, from small local manufacturers to large worldwide OEM manufacturers of the most widely recognized brands. Over the course of our 60+ year history, we\\\'ve built our reputation on delivering the best performance through our broad range of innovative technologies that optimize production to enhance molded part quality, increase productivity and lower part cost.

Molsentech

Molsentech is an innovative company centered on Bio-Nano Silicon Field-Effect Transistor (Bio-FET) technology. It focuses on developing a new generation of highly sensitive, real-time, and label-free biosensing platforms. The company is dedicated to introducing semiconductor technology into the fields of medical diagnostics and precision health, aiming to overcome the limitations of traditional detection methods in terms of speed and sensitivity, and to revolutionize early disease diagnosis and health monitoring.
Molsentech’s Bio-FET semiconductor biomedical chips and detection instruments integrate interdisciplinary technologies including IC design, microfluidic heterogeneous packaging, chemical surface modification, and high-throughput data processing. Bio-FET’s semiconductor biochip platform can instantly detect molecular targets such as nucleic acids, antibodies, antigens, and environmental chemicals in simply processed samples. It directly converts the molecular-probe binding reactions into electrical signals.
The detection process requires no fluorescent labeling or nucleic acid amplification, offering simple operation and extremely high sensitivity. This enables accurate and rapid early disease detection, addressing issues of inaccuracy or failure in early diagnostic testing, and setting a new chapter for clinical diagnostics.

MUXLINK TECHNOLOGY CORP.

後補